News

Immuneering Corporation Set to Share Insights at Healthcare Event

Immuneering Corporation Set to Share Insights at Healthcare Event

Immuneering Corporation to Present at Major Healthcare Conference

Immuneering Corporation, a progressive clinical-stage oncology company, is gearing up to present at the highly anticipated Piper Sandler 36th Annual Healthcare Conference. This event, which focuses on advancements in health and medicine, is taking place at the luxurious Lotte New York Palace. Immuneering is particularly excited about this opportunity, as it allows them to connect with other industry leaders and showcase their innovative approaches to cancer treatment.

Leadership Team Participation

The leadership team representing Immuneering includes Ben Zeskind, the Chief Executive Officer, alongside Harold "E.B." Brakewood as the Chief Business Officer and Mallory Morales, CPA, who serves as the Chief Accounting Officer and Treasurer. Together, they will discuss the company’s promising pipeline, unique platform, and comprehensive business strategy aimed at revolutionizing cancer therapies.

Format of the Presentation

The format of the presentation will be a Fireside Chat, complemented by individual meetings with investors. This setup provides an informal yet insightful environment for discussion, encouraging engagement, and fostering relationships between the Immuneering team and potential investors.

Scheduled Presentation Details

Immuneering's session is set for December 5, during which they will present from 1:00 PM to 1:25 PM ET. An intriguing aspect of this presentation is that it will be webcast live, allowing a broader audience to gain insights into their innovative work and future plans.

Webcast Details

For those unable to attend in person, the presentations will also be archived for access later. The webcast will be available in the Investor Relations section of Immuneering’s website, ensuring that investors and interested parties can stay informed about the company’s latest developments.

About Immuneering Corporation

Immuneering Corporation is dedicated to developing groundbreaking treatments targeting RAS and RAF signaling pathways, which are integral to many cancer types. Their main goal is to develop therapies that are universally effective, addressing the need for more inclusive and impactful cancer treatments.

Pipeline Overview

Immuneering’s lead product candidate, IMM-1-104, is currently in a Phase 2a clinical trial aimed at patients suffering from advanced solid tumors that include RAS mutations. Additionally, they are advancing another promising compound, IMM-6-415, into a Phase 1/2a trial. These initiatives reflect their commitment to pushing the boundaries of cancer therapy.

Ongoing Commitment to Innovation

In addition to their current trials, Immuneering is actively engaged in several earlier-stage programs that hold great potential for the future of oncology. Their efforts center around a strategic vision of harnessing Deep Cyclic Inhibition to affect cancerous cells while preserving healthy tissues, distinguishing their approach in the biotech industry.

Connecting with Stakeholders

Immuneering Corporation believes in the importance of communication and transparency with stakeholders, including investors and the public. Their ongoing updates and presentations are key to fostering trust and collaboration. For media inquiries, Gina Nugent can be reached at gina@nugentcommunications.com, while investor relations are managed by Laurence Watts at 619-916-7620.

Frequently Asked Questions

What is the Piper Sandler Healthcare Conference?

The Piper Sandler Healthcare Conference is an annual event that brings together key players in the healthcare industry to discuss innovations and share insights.

When is Immuneering presenting at the conference?

Immuneering is scheduled to present on December 5 from 1:00 PM to 1:25 PM ET.

What is Immuneering's main focus?

Immuneering Corporation focuses on developing universal-RAS/RAF medicines for cancer patients, aiming for broadly effective treatments.

Who from Immuneering will be presenting?

Ben Zeskind, Harold "E.B." Brakewood, and Mallory Morales will represent Immuneering during their presentation.

How can I access the presentation?

The presentation will be webcast live and archived on Immuneering’s Investor Relations website for later viewing.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Africa Tech Festival 2026: A Digital Turning Point

Updated Category News Views 96

Setting the Stage for Digital Advancement in Africa Come mid-November, Cape Town's gonna be buzzing with the clatter of tech titans and financial honchos making their annual pilgrimage to the Africa Tech Festival. This ain't just a conference shindig—with names like Naspers, MTN, Meta, and Amazon on the docket, it's a darn convention shaping the continent's future...

Continue Reading
Caregiving's Financial Impact on Women: Insights from Cinergy

Updated Category News Views 84

Women Caregivers Face Financial Crossroads When it comes down to it, caregiving is one heck of a responsibility, particularly for women. It's about the sacrifices they make, not just in time but in financial security, too. Step away from a job to care for someone, and it's a dicey game you're playing with future income. The Cost of Generosity: Financial Impacts Cindy...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 279

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 421

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 80

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 103

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 85

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading
ISC2 Launches AI Security Academy for Cyber Pros

Updated Category News Views 59

AI-Driven Threats Demand Expert Attention Every corner of the tech world has been blabbering about AI, but when it comes to cybersecurity, it's a whole different beast entirely. ISC2—a nonprofit that I like to think of as the cyber wizards’ guild—just threw a lifeline to cybersecurity folks who are swimming in the deep end of AI. With their shiny new AI Security...

Continue Reading
Rock Tech Uncovers Major Lithium Discovery at Victory

Updated Category News Views 59

Rock Tech's Game-Changer at Victory Folks, we've got a shake-up in the lithium landscape over in Ontario, courtesy of Rock Tech Lithium Inc. They just unearthed something quite promising at their Victory Project: a spanking new spodumene-bearing pegmatite discovery. Now I know, if you're like me, you're thinking, 'What's the angle here?' Well, this isn't just another hole...

Continue Reading

Top 5 Most Recently Viewed Articles

Citi Raises Price Target for Blackstone Amid Encouraging Outlook

Updated Category News Views 131

Citi's Updated Outlook on Blackstone Recently, Citi revisited its financial forecast for The Blackstone Group (NYSE: BX), adjusting the price target upward from $157.00 to $170.00 while maintaining a Neutral stance on the stock. This update follows the company's impressive third-quarter performance, which saw Blackstone's stock rise by 6.3% post-earnings announcement....

Continue Reading
JAB's Strategic Acquisition of Mondelez Shares in JDE Peet's

Updated Category News Views 92

JAB's Significant Move in the Coffee Industry In a strategic and noteworthy development, JAB has made headlines by agreeing to acquire a substantial share package from Mondelez, focusing on Dutch coffee giant JDE Peet's. This major transaction amounts to approximately €2.2 billion, or about $2.4 billion. JAB intends to purchase 86 million shares at a price of €25.10...

Continue Reading
Urgent Update for DXC Technology Company Investors

Updated Category News Views 272

DXC Technology Company (NYSE: DXC) found itself in hot water back in 2024 when shareholders raised hell over alleged falsehoods that inflated stock prices. The Rosen Law Firm rolled out a class action lawsuit aimed at those who bought shares during what they dubbed the Class Period—a time rife with questionable operational claims from DXC's brass. Allegations Surface:...

Continue Reading
Investigation Launched: National Grid Faces Legal Scrutiny

Updated Category News Views 283

Bragar Eagel & Squire, P.C. Initiates Investigation Bragar Eagel & Squire, P.C., a well-regarded law firm known for advocating for investors, has begun an investigation surrounding concerns related to National Grid plc (NYSE: NGG). This inquiry primarily aims to assist stockholders who may have experienced losses while owning shares of National Grid. The firm invites...

Continue Reading
Oil & Gas Sector Trends: Path to 8.79 Trillion Growth

Updated Category News Views 223

Oil & Gas Market Growth and Projections The global oil and gas market has positioned itself for remarkable expansion. With estimates currently valuing the market at approximately USD 6.10 trillion, projections suggest it could soar to around USD 8.79 trillion by 2034. This growth translates to a compound annual growth rate (CAGR) of 3.72% between 2025 and 2034. Notably,...

Continue Reading